» Articles » PMID: 17032455

A Simple Method to Combine Multiple Molecular Biomarkers for Dichotomous Diagnostic Classification

Overview
Publisher Biomed Central
Specialty Biology
Date 2006 Oct 13
PMID 17032455
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Background: In spite of the recognized diagnostic potential of biomarkers, the quest for squelching noise and wringing in information from a given set of biomarkers continues. Here, we suggest a statistical algorithm that--assuming each molecular biomarker to be a diagnostic test--enriches the diagnostic performance of an optimized set of independent biomarkers employing established statistical techniques. We validated the proposed algorithm using several simulation datasets in addition to four publicly available real datasets that compared i) subjects having cancer with those without; ii) subjects with two different cancers; iii) subjects with two different types of one cancer; and iv) subjects with same cancer resulting in differential time to metastasis.

Results: Our algorithm comprises of three steps: estimating the area under the receiver operating characteristic curve for each biomarker, identifying a subset of biomarkers using linear regression and combining the chosen biomarkers using linear discriminant function analysis. Combining these established statistical methods that are available in most statistical packages, we observed that the diagnostic accuracy of our approach was 100%, 99.94%, 96.67% and 93.92% for the real datasets used in the study. These estimates were comparable to or better than the ones previously reported using alternative methods. In a synthetic dataset, we also observed that all the biomarkers chosen by our algorithm were indeed truly differentially expressed.

Conclusion: The proposed algorithm can be used for accurate diagnosis in the setting of dichotomous classification of disease states.

Citing Articles

All-in-One, Wireless, Multi-Sensor Integrated Athlete Health Monitor for Real-Time Continuous Detection of Dehydration and Physiological Stress.

Kim K, Kang T, Kim H, Lee Y, Lee S, Yi H Adv Sci (Weinh). 2024; 11(33):e2403238.

PMID: 38950170 PMC: 11434103. DOI: 10.1002/advs.202403238.


Evaluation of the Sensitivity of Metabolic Profiling by Rapid Evaporative Ionization Mass Spectrometry: Toward More Radical Oral Cavity Cancer Resections.

Vaysse P, Demers I, van den Hout M, van de Worp W, Anthony I, Baijens L Anal Chem. 2022; 94(19):6939-6947.

PMID: 35503862 PMC: 9118195. DOI: 10.1021/acs.analchem.1c03583.


Blood amyloid and tau biomarkers as predictors of cerebrospinal fluid profiles.

Delaby C, Alcolea D, Hirtz C, Vialaret J, Kindermans J, Morichon L J Neural Transm (Vienna). 2022; 129(2):231-237.

PMID: 35169889 PMC: 8866346. DOI: 10.1007/s00702-022-02474-9.


Detection of Aberrant Glycosylation of Serum Haptoglobin for Gastric Cancer Diagnosis Using a Middle-Up-Down Glycoproteome Platform.

Jeong S, Kim U, Oh M, Nam J, Park S, Choi Y J Pers Med. 2021; 11(6).

PMID: 34207451 PMC: 8235735. DOI: 10.3390/jpm11060575.


Serum Midkine is a clinical significant biomarker for colorectal cancer and associated with poor survival.

Kemper M, Hentschel W, Grass J, Stuben B, Konczalla L, Rawnaq T Cancer Med. 2020; 9(6):2010-2018.

PMID: 31984657 PMC: 7064087. DOI: 10.1002/cam4.2884.


References
1.
Toronen P, Kolehmainen M, Wong G, Castren E . Analysis of gene expression data using self-organizing maps. FEBS Lett. 1999; 451(2):142-6. DOI: 10.1016/s0014-5793(99)00524-4. View

2.
Sharov A, Dudekula D, Ko M . A web-based tool for principal component and significance analysis of microarray data. Bioinformatics. 2005; 21(10):2548-9. DOI: 10.1093/bioinformatics/bti343. View

3.
Epstein C, Butow R . Microarray technology - enhanced versatility, persistent challenge. Curr Opin Biotechnol. 2000; 11(1):36-41. DOI: 10.1016/s0958-1669(99)00065-8. View

4.
Gaasterland T, Bekiranov S . Making the most of microarray data. Nat Genet. 2000; 24(3):204-6. DOI: 10.1038/73392. View

5.
Yang H, Carlin D . ROC surface: a generalization of ROC curve analysis. J Biopharm Stat. 2000; 10(2):183-96. DOI: 10.1081/BIP-100101021. View